社交媒体作为儿科药物安全信息来源的研究
该研究评估育儿公共论坛帖子中儿科药物不良反应、药物相关问题及用药错误的描述。共检索3573条帖子,906条提及药物,分析823条,425条描述636个药物相关问题,其中161个不良反应、95个用药错误。结果表明社交媒体信息可用于评估儿科药物不良事件并提供药物警戒补充数据。
要点
- 社交媒体帖子可提供儿科药物不良反应和用药错误的补充药物警戒数据
- 提及药物的帖子中70%包含药物相关问题,18%为不良反应,10%为用药错误
- 多数不良反应因果关系评为可能,11%为严重不良反应
核心结论
- 从社交媒体检索的信息可能有助于评估儿科药物不良事件,并提供有价值的药物警戒补充数据。
研究设计与样本
- 观察性、双向性研究,评估育儿公共论坛从建站至2021年12月关于门诊配发药物的帖子中的药物相关问题、不良反应和用药错误。
- 共检索2个育儿公共论坛的3573条帖子,906条(25%)包含药物描述,其中823条(91%)被分析。
- 不良反应因果关系采用Liverpool Causality Assessment Tool评估,严重性采用世界卫生组织标准评估。
主要发现
- 425条帖子(52%)描述了636个药物相关问题(每名儿童中位数1个,IQR 1-8)。
- 其中161个(26%)为不良反应,分布于105条帖子(每名儿童中位数1.5个,IQR 1-4);95个(15%)为用药错误,分布于64条帖子(每名儿童中位数1个,IQR 1-4)。
- 在提及药物的帖子中,70%包含药物相关问题,18%包含不良反应,10%包含用药错误。
- 大多数不良反应(158个;98%)评为可能,17个(11%)为严重不良反应。
关键数值与推荐
- 罕见不良反应19个(12%),十分罕见14个(9%),极罕见3个(2%),稀有1个(1%)。
临床怎么用
- 临床药学智能体可将社交媒体作为儿科药物警戒的补充信息来源,关注家长论坛中描述的药物不良反应和用药错误。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The paediatric population is vulnerable to suffering adverse drug events (ADEs) such as negative outcomes due to medication (NOMs)-drug related problems (DRPs), especially adverse drug reactions (ADRs) and medication errors (MEs). Social media (SM) is considered an interesting tool for pharmacovigilance. This study aims to assess descriptions of ADRs, NOM-DRPs and MEs in SM. METHODS: Observational, ambispective study assessing NOM-DRPs, ADRs and MEs in posts of child-rearing public parenting forums from inception until December 2021 of drugs dispensed in outpatient setting. ADEs were classified, assessing causality by Liverpool Causality Assessment Tool and seriousness by the World Health Organization criteria. Summary of product characteristics were used to determine ADR prevalence. RESULTS: In total, 3573 posts of 2 child-rearing public parenting forums were retrieved; 906 (25%) contained descriptions of medicine of which 823 (91%) were analysed; 425 posts (52%) described 636 NOM-DRPs (1 NOM-DRP median per child, interquartile range [IQR] 1-8), from which 161 (26%) were ADRs in 105 posts (1.5 ADR median per child, IQR 1-4) and 95 (15%) were MEs in 64 posts (1 ME median per child, IQR 1-4). From posts mined with medicines mentions, 70% included NOM-DRPs, 18% ADRs and 10% MEs. More ADRs occurred in females and infants. Most ADRs (158; 98%) were evaluated as possible and 17 ADRs (11%) were serious. Uncommon 19 (12%), (14, 9%), very rare (3, 2%) and rare (1, 1%) ADRs were also found. CONCLUSION: Results suggest that information retrieved from SM may be useful to assess paediatric ADEs and provide valuable pharmacovigilance complementary data.
引用
- Vilimelis-Piulats I, Pérez-Ricart A, Peligero MB, et al. Social media as a source of drug safety information in the paediatric population. Br J Clin Pharmacol. 2025. PMID: 39895408. doi:10.1111/bcp.16392
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。